Related Experiment Videos
Late hepatic allograft dysfunction
1Mayo Clinic Liver Transplant Center, Rochester, MN 55905, USA. rweisner@mayo.edu
Summary
Liver transplant recipients require lifelong monitoring for graft function and drug toxicity. Late graft dysfunction, often caused by disease recurrence like Hepatitis C, necessitates liver biopsy to guide treatment and improve outcomes.
Area of Science:
- Hepatology
- Transplantation Immunology
- Gastroenterology
Background:
- Liver transplant recipients need continuous monitoring for graft health, immunosuppression, and drug side effects.
- Late hepatic allograft dysfunction presents diverse causes, including rejection, infection, and disease recurrence.
Purpose of the Study:
- To review the common causes of late hepatic allograft dysfunction.
- To emphasize the importance of liver biopsy in diagnosing dysfunction.
- To discuss strategies for managing specific causes of graft dysfunction.
Main Methods:
- Literature review of studies on liver allograft dysfunction.
- Analysis of etiologies, diagnostic approaches, and management strategies.
- Synthesis of current evidence on graft survival and recurrence rates.
Main Results:
- Disease recurrence is the leading cause of late hepatic allograft dysfunction, with Hepatitis C causing cirrhosis in 28% of patients within 5 years.
- Hepatitis B recurrence is preventable with Hepatitis B immune globulin and lamivudine.
- Autoimmune liver diseases recur in 20-30% of cases, often linked to steroid withdrawal.
Conclusions:
- Liver biopsy is crucial for diagnosing rejection and guiding immunosuppressive therapy in late hepatic allograft dysfunction.
- Proactive management of Hepatitis B and careful patient selection for hepatocellular cancer transplantation can reduce recurrence.
- Drug-induced liver injury remains a significant consideration in post-transplant care.